Peptide Nasal Spray vs Injection: Which Delivery Method Is Better?

Overview of Peptide Delivery Methods

Intranasal (Nasal Spray)

Sprayed into the nostrils where the peptide absorbs through the nasal mucosa. The nasal lining is thin, highly vascularized, and for certain peptides, offers a direct pathway to the brain through olfactory and trigeminal nerves. This nose-to-brain route bypasses the blood-brain barrier, which is the whole reason nasal delivery exists for neuroactive peptides.

Subcutaneous Injection (SubQ)

Injected into the fat layer just under the skin, typically in the abdomen, thigh, or deltoid area. The peptide absorbs gradually into the bloodstream over minutes to hours. This is the most common route for peptides that need to reach systemic circulation. Bioavailability is typically close to 100%.

Intramuscular Injection (IM)

Injected directly into muscle tissue. Absorption is faster than SubQ because muscles have more blood flow. Used less commonly for peptides than for certain medications and vaccines.

Oral

Swallowed. For most peptides, this is the worst route. Stomach acid and digestive enzymes break down peptide bonds before the compound reaches your bloodstream. Oral bioavailability for most peptides is under 5%. The exceptions are peptides specifically engineered for oral delivery (like oral semaglutide/Rybelsus, which uses an absorption enhancer to survive the GI tract).

Bioavailability Comparison by Peptide

This is the table that actually matters. Bioavailability tells you what percentage of the dose you take actually reaches your system in active form.

The pattern is clear: small peptides that target the brain (Semax, Selank, oxytocin) do well nasally. Everything else generally needs to be injected.

Calculate your intranasal peptide dose

• Enter concentration and spray volume for exact sprays-per-dose
• Works for Semax, Selank, BPC-157, and any nasal peptide
• Free calculator at helloregimen.com/tools

Get Regimen Free

Advantages of Nasal Sprays

The Nose-to-Brain Pathway

This is the biggest advantage. Your nasal cavity has direct nerve connections to the brain. The olfactory nerve and the trigeminal nerve both terminate in the nasal mucosa and connect directly to brain structures. When you spray a peptide into your nose, a portion of it travels along these nerves and enters the central nervous system without ever going through the bloodstream or crossing the blood-brain barrier from the vascular side.

For peptides where the brain is the target (Semax, Selank, oxytocin), this pathway means faster onset (minutes), higher brain concentrations per dose, and less systemic exposure.

No Needles

Needle anxiety is real. For protocols that require 2-3 doses per day (common with Semax and Selank), the convenience factor is enormous. Nobody wants to inject subcutaneously three times a day. Spraying your nose three times takes about 10 seconds total.

Rapid Onset

Nasal absorption is fast. For peptides with good nasal bioavailability, you are looking at 5-15 minutes to noticeable effects. This makes nasal delivery practical for timing-dependent use (dosing before a focus session, before a social event, before a presentation).

Better Compliance

Simpler protocols get followed more consistently. People are more likely to actually take their peptide 2-3 times daily if it means spraying their nose versus loading a syringe.

Disadvantages of Nasal Sprays

• Lower bioavailability for most peptides. Outside of Selank (92.8%) and Semax (60-70%), nasal bioavailability is generally poor.
• Limited to small molecules. Peptides above roughly 20-30 amino acids generally cannot cross the nasal epithelium.
• Variable absorption. Nasal congestion, allergies, spray angle, and mucosa condition all affect how much gets absorbed.
• Nasal irritation. Regular use can cause dryness, irritation, or mild burning in the nasal passages.

Advantages of Injections

• Precise, consistent dosing. When you draw 0.3mL in a syringe, you get 0.3mL. Every time.
• High bioavailability. SubQ injection delivers close to 100% bioavailability for virtually all peptides.
• Works for all peptide sizes. There is no molecular weight cutoff for injection.
• Local targeting. For peptides like BPC-157 that work best near an injury, SubQ injection near the target tissue puts the peptide exactly where it needs to be.

Disadvantages of Injections

• Needles. Needle anxiety, injection prep time, and proper sharps disposal add friction.
• Injection site rotation and reactions. SubQ injections can cause localized redness, swelling, or small lumps. Proper site rotation is necessary.
• Sterile technique requirements. Reconstituting peptides, maintaining clean vials, using new syringes each time.
• Not ideal for brain-targeting. For brain-targeting peptides, SubQ injection actually delivers LESS to the brain per dose than nasal spray, despite higher total systemic bioavailability.

Which Peptides Are Better Nasally?

Semax. All Russian clinical research used intranasal delivery. The direct olfactory/trigeminal pathway gets Semax to the brain faster than systemic absorption from SubQ injection can. Full Semax guide.

Selank. With 92.8% intranasal bioavailability, you lose almost nothing by going nasal. And you gain the brain-direct pathway plus no needles. Full Selank guide.

Oxytocin. Systemic nasal bioavailability is very low (~2-5%), but intranasal oxytocin targets the brain directly via nerve pathways.

Which Peptides Are Better Injected?

BPC-157. Primarily used for tissue healing. SubQ injection near the injury site puts it where it needs to work. BPC-157 mixing guide.

GH Secretagogues (CJC-1295, Ipamorelin, Tesamorelin). Too large for nasal absorption and don't benefit from the nose-to-brain pathway because the target is hormonal.

GLP-1 Agonists (Semaglutide, Tirzepatide, Retatrutide). Large peptides that need sustained systemic levels. SubQ injection provides the pharmacokinetics they require. Use the peptide reconstitution calculator for injectable dosing.

TB-500. Systemic tissue repair peptide. SubQ injection provides the high bioavailability and systemic distribution TB-500 needs.

PT-141 (Bremelanotide). Originally developed as a nasal spray, switched to SubQ injection for the FDA-approved product (Vyleesi) because nasal bioavailability was only ~4%.

Decision Framework: When to Choose Each

The Regimen app lets you track both injectable and nasal protocols in the same place, including injection site rotation, nasal dosing schedules, and subjective effect tracking across all your compounds.

Frequently Asked Questions